ARCA biopharma Inc (ABIO)
3.31
+0.13
(+4.09%)
USD |
NASDAQ |
Apr 16, 12:12
ARCA biopharma Price: 3.31 for April 16, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 15, 2024 | 3.25 | 3.27 | 3.15 | 3.18 | 134428.0 |
| Apr 12, 2024 | 3.29 | 3.31 | 3.152 | 3.23 | 354128.0 |
| Apr 11, 2024 | 3.11 | 3.27 | 3.10 | 3.25 | 153877.0 |
| Apr 10, 2024 | 3.13 | 3.19 | 3.01 | 3.14 | 212918.0 |
| Apr 09, 2024 | 3.00 | 3.33 | 2.98 | 3.13 | 572724.0 |
| Apr 08, 2024 | 3.06 | 3.10 | 2.95 | 3.00 | 602930.0 |
| Apr 05, 2024 | 2.96 | 3.18 | 2.95 | 3.09 | 587228.0 |
| Apr 04, 2024 | 2.99 | 3.14 | 2.90 | 3.08 | 2.762M |
| Apr 03, 2024 | 2.91 | 3.88 | 2.88 | 3.25 | 80.81M |
| Apr 02, 2024 | 1.75 | 1.750 | 1.690 | 1.71 | 12638.00 |
| Apr 01, 2024 | 1.78 | 1.78 | 1.75 | 1.75 | 15368.00 |
| Mar 28, 2024 | 1.76 | 1.771 | 1.732 | 1.76 | 9002.00 |
| Mar 27, 2024 | 1.69 | 1.75 | 1.69 | 1.75 | 7276.00 |
| Mar 26, 2024 | 1.701 | 1.73 | 1.69 | 1.71 | 28580.00 |
| Mar 25, 2024 | 1.78 | 1.78 | 1.71 | 1.73 | 40437.00 |
| Mar 22, 2024 | 1.78 | 1.78 | 1.75 | 1.77 | 11152.00 |
| Mar 21, 2024 | 1.76 | 1.80 | 1.710 | 1.78 | 50583.00 |
| Mar 20, 2024 | 1.74 | 1.75 | 1.702 | 1.75 | 5577.00 |
| Mar 19, 2024 | 1.73 | 1.74 | 1.65 | 1.74 | 58122.00 |
| Mar 18, 2024 | 1.70 | 1.72 | 1.68 | 1.72 | 39827.00 |
| Mar 15, 2024 | 1.73 | 1.73 | 1.68 | 1.69 | 46814.00 |
| Mar 14, 2024 | 1.70 | 1.70 | 1.658 | 1.70 | 59601.00 |
| Mar 13, 2024 | 1.67 | 1.69 | 1.66 | 1.69 | 19343.00 |
| Mar 12, 2024 | 1.60 | 1.665 | 1.60 | 1.66 | 30638.00 |
| Mar 11, 2024 | 1.61 | 1.645 | 1.60 | 1.645 | 13113.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.580
Minimum
Feb 01 2024
19.21
Maximum
May 28 2020
3.538
Average
2.74
Median
Oct 19 2021
Price Benchmarks
| Shockwave Medical Inc | 327.90 |
| Asensus Surgical Inc | 0.2665 |
| Glaukos Corp | 98.17 |
| Helius Medical Technologies Inc | 5.20 |
| Perspective Therapeutics Inc | 1.495 |
Price Related Metrics
| Price to Book Value | 1.297 |
| Earnings Yield | -11.18% |
| Market Cap | 48.00M |